Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 37

Sort by

Sort Order Select

Journal Articles

The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature

Anna Mathioudaki, Xizhe Wang, David Sedloev, Richard Huth, Aryan Kamal, Michael Hundemer, Yi Liu, Spyridoula Vasileiou, Premal Lulla, Carsten Müller-Tidow, Peter Dreger, Thomas Luft, Tim Sauer, Michael Schmitt, Judith B. Zaugg, Caroline Pabst

Blood (2024) 143 (13): 1269–1281.

https://doi.org/10.1182/blood.2023021815

Published: 2024

Includes: Supplemental data

Journal Articles

Risk Factors for Omicron Pneumonia in Patients with Hematological Malignancies: A Multicenter Study in China

Li Jun, Yi Liu, Xia Wei, Zhanshu Liu, Zailiang Yang, Ling Liu, Meiyu Zhou, Guofa Xu, Lanting Chen, Yao Ding, Haike Lei, Qiying Li, Yingyu Nan, Jieping Li, Yong Zhang, Yongzhong Wu, Yao Liu

Blood (2023) 142 (Supplement 1): 3929.

https://doi.org/10.1182/blood-2023-179632

Published: 2023

Journal Articles

Neutralizing Antibody Responses in Patients with Hematological Malignancies after Omicron Infection: A Multicenter, Prospective Cohort Study in China

Blood (2023) 142 (Supplement 1): 2557.

https://doi.org/10.1182/blood-2023-179113

Published: 2023

Journal Articles

A Mutation in Complement Factor H (W1183R) Enhances VWF Proteolysis By ADAMTS13 Under Shear

Wenjing Cao, Yi Liu, X. Frank Zhang, X. Long Zheng

Blood (2023) 142 (Supplement 1): 24.

https://doi.org/10.1182/blood-2023-190083

Published: 2023

Journal Articles

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Menglin Li, Haixia Fu, Yi Liu, Hui Liu, Ru Feng, Zhao Wang, Jingwen Wang, Yuxiu Chen, Qingyuan Qu, Mengyu Xiao, Jianying Zhou, Yun He, Xiaolu Zhu, Yuan Kong, Yingjun Chang, Kaiyan Liu, Xiaohui Zhang

Blood (2023) 142 (Supplement 1): 3951.

https://doi.org/10.1182/blood-2023-182669

Published: 2023

Journal Articles

Inpatient Use of Extended-Release (ER) Opioids for Vaso-Occlusive Crisis Associated with Increased Length of Stay for ER Opioid-Naïve Patients

Madison Canning, Yi Liu, Shruti Gupta, Morgan L. McLemore, Fuad El Rassi

Blood (2023) 142 (Supplement 1): 2507.

https://doi.org/10.1182/blood-2023-179773

Published: 2023

Journal Articles

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Blood (2023) 142 (Supplement 1): 1207.

https://doi.org/10.1182/blood-2023-181622

Published: 2023

Journal Articles

Influenza Training of Granulopoiesis Promotes Long-Term Anti-Leukemia Activity

Yi Liu, Nianci Chen, Yile Zhou, Li Zhu, Zuopo Lv, Chenying Li, Jiansong Huang, Yanhong Tong, Haitao Meng, Jie Jin, Liangshun You

Blood (2023) 142 (Supplement 1): 3926.

https://doi.org/10.1182/blood-2023-179218

Published: 2023

Journal Articles

Improving Anti-Tumor Efficacy of CAR T-Cell Therapy for Acute Myeloid Leukemia (AML): Results from a Multi-Drug Interaction Screening Approach

Julia M. Unglaub, Berit Brinkmann, Qian Chen, David Sedloev, Peter-Martin Bruch, Carolin Kolb, Volker Eckstein, Yi Liu, Anita Schmitt, Simon Raffel, Michael Schmitt, Carsten Müller-Tidow, Junyan Lu, Sascha Dietrich, Tim Sauer

Blood (2023) 142 (Supplement 1): 5969.

https://doi.org/10.1182/blood-2023-181251

Published: 2023

Journal Articles

Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain

Emily R. Legan, Yi Liu, Nicholas A. Arce, Ernest T. Parker, Pete Lollar, X. Frank Zhang, Renhao Li

Blood (2023) 141 (10): 1221–1232.

https://doi.org/10.1182/blood.2022017239

Published: 2023

Includes: Supplemental data

Journal Articles

CRISPR/Cas9 Genome-Edited Autologous Hematopoietic Stem Cell Transplantation Therapies for Sickle Cell Disease

Yi Liu, Vionnie W. Yu, Qi Zhang, Madhura Panditrao, Yi Yang, Alberto Del Rio-Espinola, Daher Ibrahim Aibo, Azeddine Elhajouji, Konrad Mueller, Karin Abitorabi, Daniel O'Connell, Bo Han, Nishit Patel, Carsten Russ, Craig Mickanin, Timothy K. MacLachlan, Susan C. Stevenson

Blood (2022) 140 (Supplement 1): 12982–12983.

https://doi.org/10.1182/blood-2022-159892

Published: 2022

Journal Articles

A Sensitive Machine Learning-Based Approach to Assess Multiple Myeloma t(11;14) Genetic Subtype from Histopathology Images

Adam Stanford-Moore, Yi Liu, Chandan Akiti, Ali Behrooz, Bahar Rahsepar, Benjamin Glass, Aditee Shrotre, Jeremy A. Ross, Dorothy French

Blood (2022) 140 (Supplement 1): 7846–7847.

https://doi.org/10.1182/blood-2022-159522

Published: 2022

Journal Articles

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia-Feng, He-Bing Zhou, Qiu-Sha Huang, Yun He, Hai-Xia Fu, Xiao-Lu Zhu, Qian Jiang, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2022) 139 (3): 333–342.

https://doi.org/10.1182/blood.2021013393

Published: 2022

Includes: Supplemental data

Journal Articles

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

Ye-Jun Wu, Hui Liu, Qiao-Zhu Zeng, Yi Liu, Jing-Wen Wang, Wen-Sheng Wang, Jia Feng, He-Bing Zhou, Qiu-Sha Huang, Hai-Xia Fu, Xiao-Lu Zhu, Yun He, Hao Jiang, Ying-Jun Chang, Lan-Ping Xu, Xiao-Jun Huang, Xiao-Hui Zhang

Blood (2021) 138 (Supplement 1): 15.

https://doi.org/10.1182/blood-2021-149527

Published: 2021

Journal Articles

Binding of Gpibα to VWF A2 Domain Alters Mechanical Unraveling of the A2 Domain

Yi Liu, MS, Wenpeng Cao, PhD, Wenjing Cao, MDPhD, X. Long Zheng, MDPhD, Xiaohui Zhang, PhD

Blood (2020) 136 (Supplement 1): 24–25.

https://doi.org/10.1182/blood-2020-143275

Published: 2020

Journal Articles

Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation

Cornelius Pauli, Yi Liu, Christian Rohde, Chunhong Cui, Daria Fijalkowska, Dennis Gerloff, Carolin Walter, Jeroen Krijgsveld, Martin Dugas, Bayram Edemir, Caroline Pabst, Lutz P. Müller, Fengbiao Zhou, Carsten Müller-Tidow

Blood (2020) 135 (23): 2059–2070.

https://doi.org/10.1182/blood.2019004121

Published: 2020

Includes: Supplemental data

Journal Articles

Dissecting the Immune Cell Progeny of CAR-Expressing Hematopoietic Stem Cells in a Humanized Mouse Model

Heng-Yi Liu, Nezia Rahman, Tzu-Ting Chiou, PhD, Satiro N. De Oliveira, MD

Blood (2019) 134 (Supplement_1): 4640.

https://doi.org/10.1182/blood-2019-129746

Published: 2019

Journal Articles

Combination of ATRA and High-Dose Dexamethasone As First-Line Treatment in Adult Immune Thrombocytopenia:a Randomized, Phase 2, Open-Label Trial

Qiu-Sha Huang, Yi Liu, Jing-Bo Wang, Jun Peng, Ming Hou, Hui Liu, Jing-Wen Wang, Lan-Ping Xu, Kaiyan Liu, Xiao-Jun Huang, MD, Xiao-Hui Zhang

Blood (2019) 134 (Supplement_1): 899.

https://doi.org/10.1182/blood-2019-125242

Published: 2019

Journal Articles

Recombinant Human Thrombopoietin Increases Platelet Numbers and Reduces the Risk of Bleeding Events in Thrombocytopenic Patients with Chronic Hepatitis B Virus Infection: A Multicenter Observational Study

Blood (2018) 132 (Supplement 1): 4990.

https://doi.org/10.1182/blood-2018-99-116000

Published: 2018

Journal Articles

Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan

Hsin-An Hou, MD, PhD, Chao-Hsiun Tang, PhD, Hung-Yi Liu, Hong Qiu, MD PhD, Sarah Siggins, PhD, Lee Anne Rothwell, PhD, Ya-Wen Yang, Sung-Nan Pei, MD, Yongjing Zhang, MD PhD, Yanfang Liu, MD MPH

Blood (2017) 130 (Supplement 1): 5434.

https://doi.org/10.1182/blood.V130.Suppl_1.5434.5434

Published: 2017

NARROW

The remission status of AML patients after allo-HCT is associated with a distinct single-cell bone marrow T-cell signature

Risk Factors for Omicron Pneumonia in Patients with Hematological Malignancies: A Multicenter Study in China

Neutralizing Antibody Responses in Patients with Hematological Malignancies after Omicron Infection: A Multicenter, Prospective Cohort Study in China

A Mutation in Complement Factor H (W1183R) Enhances VWF Proteolysis By ADAMTS13 Under Shear

Biomarker MSC-C5b-9-Guided Master Therapies for Resistant/Recurrent ITP: A Prospective, Randomized, Open-Label, Multicenter Trial

Inpatient Use of Extended-Release (ER) Opioids for Vaso-Occlusive Crisis Associated with Increased Length of Stay for ER Opioid-Naïve Patients

Baricitinib in Combination with High-Dose Dexamethasone As First-Line Treatment for Newly Diagnosed Immune Thrombocytopenia: A Prospective, Multicenter, Randomized Trial

Influenza Training of Granulopoiesis Promotes Long-Term Anti-Leukemia Activity

Improving Anti-Tumor Efficacy of CAR T-Cell Therapy for Acute Myeloid Leukemia (AML): Results from a Multi-Drug Interaction Screening Approach

Type 2B von Willebrand disease mutations differentially perturb autoinhibition of the A1 domain

CRISPR/Cas9 Genome-Edited Autologous Hematopoietic Stem Cell Transplantation Therapies for Sickle Cell Disease

A Sensitive Machine Learning-Based Approach to Assess Multiple Myeloma t(11;14) Genetic Subtype from Histopathology Images

All- trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP

All-Trans Retinoic Acid Plus Low-Dose Rituximab Vs Low-Dose Rituximab in Corticosteroid-Resistant or Relapsed ITP

Binding of Gpibα to VWF A2 Domain Alters Mechanical Unraveling of the A2 Domain

Site-specific methylation of 18S ribosomal RNA by SNORD42A is required for acute myeloid leukemia cell proliferation

Dissecting the Immune Cell Progeny of CAR-Expressing Hematopoietic Stem Cells in a Humanized Mouse Model

Combination of ATRA and High-Dose Dexamethasone As First-Line Treatment in Adult Immune Thrombocytopenia:a Randomized, Phase 2, Open-Label Trial

Recombinant Human Thrombopoietin Increases Platelet Numbers and Reduces the Risk of Bleeding Events in Thrombocytopenic Patients with Chronic Hepatitis B Virus Infection: A Multicenter Observational Study

Real World Treatment Patterns and Survival in Patients with Multiple Myeloma (MM) in Taiwan

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only